This blog is related to the various litigations related to patents w.r.t pharma industry.
Sunday, August 2, 2009
Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL
Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Risperidone Oral Solution, 1mg/mL by the U.S. Food and Drug Administration.
No comments:
Post a Comment